↓ Skip to main content

A concise review of the efficacy of stereotactic radiosurgery in the management of melanoma and renal cell carcinoma brain metastases

Overview of attention for article published in World Journal of Surgical Oncology, August 2012
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age and source (64th percentile)

Mentioned by

twitter
1 X user
facebook
1 Facebook page

Citations

dimensions_citation
26 Dimensions

Readers on

mendeley
51 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
A concise review of the efficacy of stereotactic radiosurgery in the management of melanoma and renal cell carcinoma brain metastases
Published in
World Journal of Surgical Oncology, August 2012
DOI 10.1186/1477-7819-10-176
Pubmed ID
Authors

Peter W Hanson, Ameer L Elaimy, Wayne T Lamoreaux, John J Demakas, Robert K Fairbanks, Alexander R Mackay, Blake Taylor, Barton S Cooke, Sudheer R Thumma, Christopher M Lee

Abstract

Melanoma and renal cell carcinoma have a well-documented tendency to develop metastases to the brain. Treating these lesions has traditionally been problematic, because chemotherapy has difficulty crossing the blood brain barrier and whole brain radiation therapy (WBRT) is a relatively ineffective treatment against these radioresistant tumor histologies. In recent years, stereotactic radiosurgery (SRS) has emerged as an effective and minimally-invasive treatment modality for irradiating either single or multiple intracranial structures in one clinical treatment setting. For this reason, we conducted a review of modern literature analyzing the efficacy of SRS in the management of patients with melanoma and renal cell carcinoma brain metastases. In our analysis we found SRS to be a safe, effective and attractive treatment modality for managing radioresistant brain metastases and highlighted the need for randomized trials comparing WBRT alone vs. SRS alone vs. WBRT plus SRS in treating patients with radioresistant brain metastases.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 51 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 2%
Belgium 1 2%
Unknown 49 96%

Demographic breakdown

Readers by professional status Count As %
Researcher 9 18%
Other 8 16%
Student > Ph. D. Student 5 10%
Student > Master 5 10%
Student > Postgraduate 4 8%
Other 10 20%
Unknown 10 20%
Readers by discipline Count As %
Medicine and Dentistry 23 45%
Physics and Astronomy 4 8%
Agricultural and Biological Sciences 3 6%
Neuroscience 2 4%
Biochemistry, Genetics and Molecular Biology 2 4%
Other 4 8%
Unknown 13 25%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 October 2012.
All research outputs
#17,665,425
of 22,678,224 outputs
Outputs from World Journal of Surgical Oncology
#878
of 2,038 outputs
Outputs of similar age
#125,622
of 170,146 outputs
Outputs of similar age from World Journal of Surgical Oncology
#20
of 64 outputs
Altmetric has tracked 22,678,224 research outputs across all sources so far. This one is in the 19th percentile – i.e., 19% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,038 research outputs from this source. They receive a mean Attention Score of 2.0. This one has gotten more attention than average, scoring higher than 50% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 170,146 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 23rd percentile – i.e., 23% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 64 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 64% of its contemporaries.